Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis

Neurological Research

Volumn 30, Issue 8, 2008, Pages 816-826

  Zivadinov, Robert ^a,b   Bergsland, Niels ^a   Stosic, Milena ^a   Sharma, Jitendra ^b   Nussenbaum, Fernando ^a   Durfee, Jacqueline ^a   Hani, Nima ^a   Abdelrahman, Nadir ^a   Jaisani, Zeenat ^b   Minagar, Alireza ^c   Hoque, Romy ^c   Munschauer III, Frederick E ^b   Dwyer, Michael G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Acute ischemic stroke; Chronic ischemic stroke; Demyelinating lesions; Diffusion weighted imaging; Multiple sclerosis; Perfusion weighted imaging

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CONTRAST ENHANCEMENT; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FALSE POSITIVE RESULT; FEMALE; FLAIR ATTENUATED INVERSION RECOVERY IMAGING; GRAY MATTER; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; PERFUSION WEIGHTED IMAGING; WHITE MATTER;

AGED; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PERFUSION; STROKE;

EID: 53549124118     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313208X341003     Document Type: Article

References (50)

1. Ginsberg M, Pulsinelli W. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol 1994; 36: 553-554
2. Guadagno JV, Donnan GA, Markus R, et al. Imaging the ischaemic penumbra. Curr Opin Neurol 2004; 17: 61-67
3. Tatlisumak T, Strbian D, Abo Ramadan U, et al. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics. Curr Vasc Pharmacol 2004; 2: 343-355
4. Schlaug G, Benfield A, Baird A, et al. The ischemic penumbra: Operationally defined by diffusion and perfusion MRI. Neurology 1999; 53: 1528-1537
5. Beaulieu C, de Crespigny A, Tong D, et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome. Ann Neurol 1999; 46: 568-578
6. Zivadinov R. Evidence for neuroprotection in multiple sclerosis: Can imaging techniques measure neuroprotection and remyelination? Neurology 2007; 68 (Suppl. 3): S72-S82
7. Rovaris M, Gass A, Bammer R, et al. Diffusion MRI in multiple sclerosis. Neurology 2005; 65: 1526-1532
8. Horsfield MA, Larsson HB, Jones DK, et al. Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64 (Suppl. 1): S80-S84
9. Cercignani M, Inglese M, Pagani E, et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001; 22: 952-958
10. Tavazzi E, Dwyer MG, Weinstock-Guttman B, et al. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Neuroimage 2007; 36: 746-754
11. Lin F, Yu C, Jiang T, et al. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 2007; 28: 278-282
12. Rovaris M and Filippi M. Diffusion tensor MRI in multiple sclerosis. J Neuroimaging 2007; 17 (Suppl. 1): S27-S30
13. Wuerfel J, Paul F, Zipp F. Cerebral blood perfusion changes in multiple sclerosis. J Neurol Sci 2007; 259: 16-20
14. Firbank M, Coulthard A, Harrison R, et al. Partial volume effects in MRI studies of multiple sclerosis. Magn Reson Imaging 1999; 17: 593-601
15. Haselhorst R, Kappos L, Bilecen D, et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction. J Magn Reson Imaging 2000; 11: 495-505
16. Sakaie KE, Shin W, Curtin KR, et al. Method for improving the accuracy of quantitative cerebral perfusion imaging. J Magn Reson Imaging 2005; 21: 512-519
17. Inglese M, Park SJ, Johnson G, et al. Deep gray matter perfusion in multiple sclerosis: Dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007;64:196-202
18. Adhya S, Johnson G, Herbert J, et al. Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage 2006; 33: 1029-1035
19. Law M, Saindane AM, Ge Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: Perfusion MR imaging findings in normal-appearing white matter. Radiology 2004; 231: 645-652
20. Saindane AM, Law M, Ge Y, et al. Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: Support for primary hypoperfusion in multiple sclerosis. AJNR Am J Neuroradiol 2007; 28: 767-772
21. Rashid W, Parkes LM, Ingle GT, et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 1288-1293
22. Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008; 28: 164-171
23. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452
25. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-911
26. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54: 683-688
27. Zivadinov R, Rudick RA, De Masi R, et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001; 57: 1239-1247
28. Zivadinov R, Sepcic J, Nasuelli D, et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 70: 773-780
29. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249-265
30. Morgan B, Utting JF, Higginson A, et al. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer 2006; 94: 1420-1427
31. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000; 11 (6 Pt 1): 805-821
32. Ashburner J, Friston K. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999; 7: 254-266
33. Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825-841
34. Gonzalez R, Woods R. Digital Image Processing, Chapter 2, Boston, MA: Addison-Wesley Publishing Company, 1992
35. John H, Langley P. Estimating continuous distributions in Bayesian classifiers. Paper presented at the 11st Conference on Uncertainty in Artificial Intelligence, 1995, Montreal, Que., Canada
36. Landwehr M, Frank E. Logistic model trees. Paper presented at the 14th European Conference on Machine Learning, 2003, Cavtat-Dubrovnik, Croatia
37. Le Cessie S, van Houwelingen JC. Ridge estimators in logistic regression. Appl Stat 1992; 41: 191-201
38. Rosso C, Remy P, Creange A, et al. Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. AJNR Am J Neuroradiol 2006; 27: 1006-1008
39. Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 1999; 20: 1491-1499
40. Horsfield MA, Lai M, Webb SL, et al. Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 1996; 36: 393-400
41. Lovblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 1998; 19: 1061-1066
42. Hoque R, Ledbetter C, Gonzalez-Toledo E, et al. The role of quantitative neuroimaging indices in the differentiation of ischemia and demyelination. A study and case analysis. Int Rev Neurobiol 2007; 79: 491-519
43. Rabinstein AA. Treatment of cerebral edema. Neurologist 2006; 12: 59-73
44. van der Voorn JP, Pouwels PJ, Hart AA, et al. Childhood white matter disorders: Quantitative MR imaging and spectroscopy. Radiology 2006; 241: 510-517
45. Rovaris M, Holtmannspotter M, Rocca MA, et al. Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: A preliminary study. Mult Scler 2002; 8: 52-58
46. Govoni M, Castellino G, Padovan M, et al. Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 2004; 13: 149-158
47. Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999; 30: 2043-2052
48. Read SJ, Hirano T, Abbott DF, et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 2000; 48: 228-235
49. Ge Y, Law M, Johnson G, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: Characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 2005; 26: 1539-1547
50. Butcher K, Parsons M, Baird T, et al. Perfusion thresholds in acute stroke thrombolysis. Stroke 2003; 34: 2159-2164